Fluticasone furoate nasal spray reduces symptoms of uncomplicated acute rhinosinusitis: a randomised placebo-controlled study

Primary Care Respiratory Journal, 05/30/2012

Fluticasone furoate nasal spray (FFNS) reduces symptoms of uncomplicated acute rhinosinusitis (ARS) compared with placebo and is well tolerated, providing support for withholding antibiotics in selected patients.

Print Article Summary